LMR Partners’s HUMANIGEN, INC. HGEN Stock Holding History

LMR Partners’s Portfolio HGEN Stock Details HGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-17,406	Closed	-$3K	–	1407
2022 Q3	$3K	Buy	+17,406	New	+$9.37K	﹤0.01%	1199
2021 Q2	–	Sell	-25,927	Closed	-$495K	–	1420
2021 Q1	$495K	Buy	+25,927	New	+$473K	0.01%	638

Other funds holding HGEN

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LMR Partners's HGEN Position: Q4 2022 in Review

LMR Partners sold out of HUMANIGEN, INC. (HGEN) in Q4 2022, closing a stake of 17,406 shares — an estimated $3K sold.

LMR Partners first reported a position in HGEN in Q1 2021 and held it in 2 quarters. The position peaked at $495K in Q1 2021. 48 funds tracked by Wall St. Rank hold HGEN as of Q4 2022.

LMR Partners reported no remaining HUMANIGEN, INC. position as of Q4 2022 after selling out during the quarter.
LMR Partners sold 17,406 HUMANIGEN, INC. shares in Q4 2022, an estimated $3K.
LMR Partners first reported a position in HUMANIGEN, INC. in Q1 2021 and held it in 2 quarters.
LMR Partners's HUMANIGEN, INC. position peaked at $495K in Q1 2021.
48 funds tracked by Wall St. Rank held HUMANIGEN, INC. as of Q4 2022.

Based on LMR Partners's 13F filing for Q4 2022, filed 14 Feb 2023.